In terms of market performance, Intellia Therapeutics Inc had a fairly uneven.
52-week price history of NTLA Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Intellia Therapeutics Inc’s current trading price is -68.91% away from its 52-week high, while its distance from the 52-week low is 48.47%. The stock’s price range during the 52-week period has remained between $5.90 and $28.18. In the Healthcare sector, the company’s shares saw a trading volume of around 2.44 million for the day, which was evidently lower than the average daily volume of 4.11 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Intellia Therapeutics Inc (NTLA) has experienced a quarterly decline of -5.81% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 907.39M and boasts a workforce of 403 employees.
Making Sense of Trading Volume and Moving Average Data
Examining NTLA’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for NTLA stands at 0.15. Similarly, the long-term debt-to-equity ratio is also 0.10.
NTLA Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Until today this year the stock’s price performance recorded a decrease of -24.87%. However, over the last six months, the performance has been stronger by -35.82%. The price of NTLA increased 7.88% over the last 30 days. And in the last five days, it has surged by 13.91%.
